Payoneer Global Inc. 8-K

What Happened
Payoneer Global Inc. announced on June 15, 2026 (Merger Agreement dated June 12, 2026) that it has entered into an agreement to be acquired by Neon Maple Parent Inc. (Nuvei) through a merger in which Payoneer will become a wholly owned subsidiary of Nuvei. Under the agreement, each outstanding share of Payoneer common stock will convert into $7.40 in cash (no interest) at the effective time, subject to closing conditions and required approvals.

Key Details

• Purchase price: $7.40 per share in cash for each issued and outstanding Payoneer common share.
• Approvals & timing: Transaction requires Payoneer stockholder approval (majority vote), antitrust/HSR clearance and other regulatory approvals (including foreign investment and money transmitter licenses). Target outside date is June 12, 2027, with a possible three-month extension to obtain regulatory approvals.
• Support: Certain stockholders holding ~19% of voting power signed voting/support agreements in favor of the merger.
• Equity awards: Vested options/RSUs/PSUs will be cashed out (generally at $7.40 less exercise price for options); unvested awards convert to deferred cash awards with time-based vesting. Special accelerated vesting: CEO John Caplan will receive 75% acceleration at closing (remaining 25% vesting nine months later under his letter agreement); CFO Bea Ordonez will receive 50% acceleration for certain awards. Options with exercise price ≥ $7.40 are cancelled for no consideration.
• Termination fees & remedies: If Payoneer terminates to accept a superior proposal or breaches certain covenants, Payoneer may owe Nuvei an $89M termination fee. Nuvei could owe Payoneer a $165M termination fee in certain failure scenarios; in some breach/fraud cases Payoneer may instead seek damages up to a $275M cap.

Why It Matters
This is a cash acquisition that, if approved and completed, would give Payoneer shareholders $7.40 per share and take the company private as a Nuvei subsidiary. The deal is subject to shareholder and regulatory approvals and contains significant provisions on how employee equity will be treated and what fees apply if the deal is terminated. Investors should watch for the proxy statement, the company stockholder vote, and regulatory clearance milestones for updates on timing and potential changes.